Evaluating the number of stages in development of squamous cell and adenocarcinomas across cancer sites using human population-based cancer modeling

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Kravchenko, Julia ^a   Akushevich, Igor ^a   Abernethy, Amy P ^a   Lyerly, H Kim ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; AGE; AGED; ANAL SQUAMOUS CELL CARCINOMA; ANUS CARCINOMA; ARTICLE; BREAST ADENOCARCINOMA; CANCER GROWTH; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER MODEL; CANCER REGISTRY; CANCER STAGING; CARCINOGENESIS; CLINICAL ARTICLE; COLON ADENOCARCINOMA; CONTROLLED STUDY; DISEASE ASSOCIATION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GINGIVA TUMOR; GUM SQUAMOUS CELL CARCINOMA; HISTOPATHOLOGY; HUMAN; HYPOPHARYNX CARCINOMA; HYPOPHARYNX SQUAMOUS CELL CARCINOMA; KIDNEY CARCINOMA; LARYNX SQUAMOUS CELL CARCINOMA; LIP CARCINOMA; LIP SQUAMOUS CELL CARCINOMA; LIVER ADENOCARCINOMA; LIVER CARCINOMA; LUNG ADENOCARCINOMA; LUNG SQUAMOUS CELL CARCINOMA; MALE; MATHEMATICAL MODEL; MOUTH SQUAMOUS CELL CARCINOMA; OVARY ADENOCARCINOMA; PANCREAS ADENOCARCINOMA; PROSTATE ADENOCARCINOMA; RECTUM CARCINOMA; SENSITIVITY ANALYSIS; SQUAMOUS CELL CARCINOMA; STOMACH ADENOCARCINOMA; TONGUE CARCINOMA; TONSIL CARCINOMA; TONSIL SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA; UTERUS CARCINOMA; VULVA CARCINOMA; VULVAR SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; LUNG NEOPLASMS; MIDDLE AGED; MODELS, STATISTICAL; SEER PROGRAM; SENSITIVITY AND SPECIFICITY; UNITED STATES; UTERINE CERVICAL NEOPLASMS;

EID: 84861313043     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037430     Document Type: Article

References (65)

1. Coy P, Elwood J, Coldman A, (1981) Clinical indicators of prognosis in unresected lung cancer. Chest 80: 453.
2. Gail MH, Eagan RT, Feld R, Ginsberg R, Goodell B, et al. (1984) Prognostic factors in patients with resected stage I non small cell lung cancer. A report from the Lung Cancer Study Group. Cancer 54: 1802-1813.
3. Rosenthal SA, Curran WJ, (1990) The significance of histology in non-small cell lung cancer. Cancer Treatment Reviews 17: 409-425.
4. Janssen-Heijnen ML, Coebergh JW, (2001) Trends in incidence and prognosis of the histological subtypes of lung cancer in North America, Australia, New Zealand and Europe. Lung Cancer 31: 123-137.
5. Blot WJ MJ, Fraumeni JF Jr, (2006) Esophageal Cancer. In: Schottenfeld D FJ, Jr, editors. Cancer Epidemiology and Prevention Oxford University Press pp. 697-706.
6. Schiffman MH HA, (2006) Cervical Cancer. In: Schottenfeld D FJ, Jr, editors. Cancer Epidemiology and Prevention Oxford University Press pp. 1044-1067.
7. Boffetta P, Trichopoulos D, (2002) Cancer of the lung, larynx, and pleura. In: Adami H-O, Hunter D, Trichopoulos D, editors. Textbook of cancer epidemiology Oxford University Press pp. 248-280.
8. Chiosea S, Jelezcova E, Chandran U, Luo J, Mantha G, et al. (2007) Overexpression of Dicer in precursor lesions of lung adenocarcinoma. Cancer Research 67: 2345-2350.
9. Thune I, Lund E, (1997) The influence of physical activity on lung-cancer risk- A prospective study of 81,516 men and women. International Journal of Cancer 70: 57-62.
10. Lagergren J, Bergström R, Nyrén O, (1999) Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Annals of Internal Medicine 130: 883.
11. Green J, Berrington de Gonzalez A, Sweetland S, Beral V, Chilvers C, et al. (2003) Risk factors for adenocarcinoma and squamous cell carcinoma of the cervix in women aged 20-44 years: the UK National Case-Control Study of Cervical Cancer. British Journal of Cancer 89: 2078-2086.
12. Yoshida H, Sumi T, Hyun Y, Nakagawa E, Hattori K, et al. (2003) Expression of survivin and matrix metalloproteinases in adenocarcinoma and squamous cell carcinoma of the uterine cervix. Oncology Reports 10: 45-49.
13. Sato S, Nakamura Y, Tsuchiya E, (1994) Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung. Cancer Research 54: 5652.
14. Pierce DA, Mendelsohn ML, (1999) A model for radiation-related cancer suggested by atomic bomb survivor data. Radiation Research 152: 642-654.
15. Henson DE, Schwartz AM, Nsouli H, Albores-Saavedra J, (2009) Carcinomas of the pancreas, gallbladder, extrahepatic bile ducts, and ampulla of vater share a field for carcinogenesis: a population-based study. Archives of Pathology and Laboratory Medicine 133: 67-71.
16. Manton K, Akushevich I, Kravchenko J, (2009) Cancer Mortality and Morbidity Patterns in the U.S. population: An Interdisciplinary Approach; Gail M, Krickeberg, K., Samet, J., Tsiatis, A., Wong, W., editor. New York, NY Springer.
17. Armitage P, Doll R, (1954) The age distribution of cancer and a multi-stage theory of carcinogenesis. British Journal of Cancer 8: 1.
18. Manton K, Akushevich I, Kulminski A, (2008) Human Mortality at Extreme Ages: Data from the NLTCS and Linked Medicare Records. Mathematical Population Studies 15: 137-159.
19. Moolgavkar SH, (1988) Biologically motivated two-stage model for cancer risk assessment. Toxicology Letters 43: 139-150.
20. Knudson AG, (2001) Two genetic hits (more or less) to cancer. Nature Reviews Cancer 1: 157-162.
21. Brown LD, Cai TT, DasGupta A, (2001) Interval estimation for a binomial proportion. Statistical Science 16: 101-133.
22. Rieker RJ, Hoegel J, Kern MA, Steger C, Aulmann S, et al. (2008) A Mathematical Approach Predicting the Number of Events in Different Tumors. Pathology & Oncology Research 14: 199-204.
23. Yashin AI, Akushevich I, Arbeev K, Akushevich L, Kulminski A, et al. (2009) Studying health histories of cancer: A new model connecting cancer incidence and survival. Mathematical Biosciences 218: 88-97.
24. Moolgavkar SH, Meza R, Turim J, (2009) Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973-2005. Cancer Causes and Control 20: 935-944.
25. Kravchenko J, Akushevich I, Seewaldt VL, Abernethy AP, Lyerly HK, (2011) Breast cancer as heterogeneous disease: contributing factors and carcinogenesis mechanisms. Breast Cancer Research and Treatment 128: 483-493.
26. Calabrese P, Mecklin JP, Jarvinen HJ, Aaltonen LA, Tavare S, et al. (2005) Numbers of mutations to different types of colorectal cancer. BMC Cancer 5: 126.
27. Slaughter DP, Southwick HW, Smejkal W, (1953) "Field cancerization" in oral stratified squamous epithelium. Clinical implications of multicentric origin. Cancer 6: 963-968.
28. Kawase A, Yoshida J, Ishii G, Nakao M, Aokage K, et al. (2012) Differences Between Squamous Cell Carcinoma and Adenocarcinoma of the Lung: Are Adenocarcinoma and Squamous Cell Carcinoma Prognostically Equal? Japanese Journal of Clinical Oncology 42: 189-195.
29. Kondo M, Dono K, Sakon M, Shimizu J, Nagano H, et al. (2002) Adenosquamous carcinoma of the gallbladder. Hepatogastroenterology 49: 1230-1234.
30. Peterson P, Park K, Fossella F, Gatzemeier U, John W, et al. (2007) Is pemetrexed more effective in adenocarcinoma and large cell lung cancer than in squamous cell carcinoma? A retrospective analysis of a phase III trial of pemetrexed vs docetaxel in previously treated patients with advanced non-small cell lung cancer (NSCLC): P2-328. Journal of Thoracic Oncology 2: S851.
31. Terry J, Leung S, Laskin J, Leslie KO, Gown AM, et al. (2010) Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples. Am J Surg Pathol 34: 1805-1811.
32. Areses K, Anido U, Ruibal A, Abdulkader I, Gude F, et al. (2010) Biologic differences between squamous cell carcinomas and denocarcinomas of the lung demonstrated by tissue arrays: Interest for the 18F-FDG-PET. J Clin Oncol 28.
33. Lindstrom AK, Tot T, Stendahl U, Syrjanen S, Syrjanen K, et al. (2009) Discrepancies in expression and prognostic value of tumor markers in adenocarcinoma and squamous cell carcinoma in cervical cancer. Anticancer Res 29: 2577-2578.
34. Hassan KA, Chen G, Kalemkerian GP, Wicha MS, Beer DG, (2009) An embryonic stem cell-like signature identifies poorly differentiated lung adenocarcinoma but not squamous cell carcinoma. Clin Cancer Res 15: 6386-6390.
35. Schottenfeld D, Beebe-Dimmer JL, (2006) Multiple Primary Cancers. In: Schottenfeld D, Fraumeni JFJ, editors. Cancer Epidemiology and Prevention Oxford University Press.
36. Cook GB, (1966) A comparison of single and multiple primary cancers. Cancer 19: 959-966.
37. Hayat MJ, Howlader N, Reichman ME, Edwards BK, (2007) Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. The Oncologist 12: 20.
38. Okarmoto T, Ohno Y, Tsugane S, Watanabe S, Shimoyama M, et al. (1989) Multi step Carcinogenesis Model for Adult T cell Leukemia. Cancer Science 80: 191-195.
39. Grotmol T, Bray F, Holte H, Haugen M, Kunz L, et al. (2011) Frailty Modeling of the Bimodal Age-Incidence of Hodgkin Lymphoma in the Nordic Countries. Cancer Epidemiology Biomarkers & Prevention 20: 1350.
40. Jones S, Zhang X, Parsons DW, Lin JCH, Leary RJ, et al. (2008) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321: 1801.
41. Wood LD, Parsons DW, Jones S, Lin J, Sjöblom T, et al. (2007) The genomic landscapes of human breast and colorectal cancers. Science 318: 1108.
42. Meza R, Jeon J, Moolgavkar SH, Luebeck EG, (2008) Age-specific incidence of cancer: Phases, transitions, and biological implications. Proceedings of the National Academy of Sciences of the United States of America 105: 16284-16289.
43. Armitage P, Doll R, (1957) A two-stage theory of carcinogenesis in relation to the age distribution of human cancer. British Journal of Cancer 11: 161.
44. Moolgavkar SH, Knudson AG Jr, (1981) Mutation and cancer: A model for human carcinogenesis. Journal of the National Cancer Institute 66: 1037.
45. Tan WY, (1991) Stochastic models of carcinogenesis: CRC.
46. Luebeck EG, Moolgavkar SH, (2002) Multistage carcinogenesis and the incidence of colorectal cancer. Proceedings of the National Academy of Sciences 99: 15095.
47. Little M, Wright E, (2003) A stochastic carcinogenesis model incorporating genomic instability fitted to colon cancer data. Mathematical Biosciences 183: 111-134.
48. Vogelstein B, Kinzler KW, (2004) Cancer genes and the pathways they control. Nature Medicine 10: 789-799.
49. Kinzler KW, Vogelstein B, (1996) Lessons from Hereditary Review Colorectal Cancer. Cell 87: 159-170.
50. Fearon ER, Vogelstein B, (1990) A genetic model for colorectal tumorigenesis. Cell 61: 759-767.
51. Karayi M, Markham A, (2004) Molecular biology of prostate cancer. Prostate Cancer and Prostatic Diseases 7: 6-20.
52. Van Dyke T, Jacks T, (2002) Cancer Modeling in the Modern Era:: Progress and Challenges. Cell 108: 135-144.
53. Akushevich IV, Veremeyeva GA, Dimov GP, Ukraintseva SV, Arbeev KG, et al. (2010) Modeling Deterministic Effects in Hematopoietic System Caused By Chronic Exposure To Ionizing Radiation in Large Human Cohorts. Health Physics 99: 322-329.
54. Veremeyeva G, Akushevich I, Ukraintseva S, Yashin A, Epifanova S, et al. (2010) A new approach to individual prognostication of cancer development under conditions of chronic radiation exposure. International Journal of Low Radiation 7: 53-80.
55. Akushevich I, Veremeyeva G, Kravchenko J, Ukraintseva S, Arbeev K, et al. (2012) New Stochastic Carcinogenesis Model with Covariates: an Approach Involving Intracellular Barrier Mechanisms. Mathematical Biosciences 236: 16-30.
56. de Rijke JM, Schouten LJ, Hillen HFP, Kiemeney L, Coebergh JWW, et al. (2000) Cancer in the very elderly Dutch population. Cancer 89: 1121-1133.
57. DePinho RA, (2000) The age of cancer. Nature 408: 248-254.
58. Piantanelli L, (1988) Cancer and aging- from the kinetics of biological parameters to the kinetics of cancer incidence and mortality. Annals of the New York Academy of Sciences 521: 99-109.
59. Smith DWE, (1999) Resistance to causes of death: a study of cancer mortality resistance in the oldest old. In: Robine JM, Forette B, Franceschi C, Allard M, editors. Longevity: The Paradoxes of Longevity Berlin-Heidelberg-New York Springer-Verlag pp. 61-71.
60. Miyaishi O, Ando F, Matsuzawa K, Kanawa R, Isobe K, (2000) Cancer incidence in old age. Mechanisms of Ageing and Development 117: 47-55.
61. Stanta G, Campagner L, Cavalieri F, Giarelli L, (1997) Cancer of the oldest old- What we have learned from autopsy studies. Clinics in Geriatric Medicine 13 55-&.
62. Bonafe M, Valensin S, Gianni W, Marigliano V, Franceschi C, (2001) The unexpected contribution of immunosenescence to the leveling off of cancer incidence and mortality in the oldest old. Critical Reviews in Oncology Hematology 39: 227-233.
63. Forman D, (2002) Counting cancers at the junction-a problem of routine statistics. European Journal of Gastroenterology and Hepatology 14: 99.
64. Hazelton WD, Clements MS, Moolgavkar SH, (2005) Multistage carcinogenesis and lung cancer mortality in three cohorts. Cancer Epidemiology Biomarkers & Prevention 14: 1171.
65. Schöllnberger H, Manuguerra M, Bijwaard H, Boshuizen H, Altenburg H, et al. (2006) Analysis of epidemiological cohort data on smoking effects and lung cancer with a multi-stage cancer model. Carcinogenesis 27: 1432.